Could cells from menstrual blood be a new source for cell-based therapies?

Other OA: hybrid CC0
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Endometrial cells shed during menstruation exhibit high replicative and differentiation potential, making them a promising alternative source for cell-based therapies.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Human endometrium is a highly regenerative tissue and contains a low number of cells which have high replicative ability and differentiation efficiency. This has been identified by many scientists. When the fresh growth of tissue and blood vessels is shed during each menstrual cycle, some cells with regenerative capabilities are present. Reports have also indicated that these cells possess the capacity to trans-differentiate into mesodermal, ectodermal and endodermal lineages by using standard commercially available culture reagents and methodologies. Given the ease of extraction and pluripotency of this cell population, we propose it as a novel alternative to current cells sources for cell-based therapies.

My notes (saved in your browser only)

MeSH descriptors

Blood Cells Blood Component Transfusion Blood Component Transfusion Cell Transplantation Endometrium Menstruation Blood Cells Blood Component Transfusion Cell Transplantation Endometrium Female Humans Menstruation

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (18)

SciLite annotations

organisms 1
human

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:06:07.402396+00:00
scilite
last seen: 2026-05-18T04:25:29.313245+00:00
License: CC0 · commercial use OK